CardioMetabolic Risk Test

$250.00

SpectraCell’s CardioMetabolic, Pre-Diabetes, and LPP™ Plus Tests offer clinically relevant evaluation to help define risk for atherosclerotic cardiovascular disease (ASCVD), progression toward Type 2 Diabetes, and inflammation.

Description

CardioMetabolic Risk

Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before a diagnosis of Type 2 Diabetes. SpectraCell’s CardioMetabolic, Pre-Diabetes, and LPP™ Plus Tests offer clinically relevant evaluation to help define risk for atherosclerotic cardiovascular disease (ASCVD), progression toward Type 2 Diabetes, and inflammation. These check points, along with a new CardioMetabolic Risk Assessment and Type 2 Diabetes Risk Assessment, help patients understand that not just one factor, but rather a constellation of factors, contributes to the genesis and progression toward cardiovascular disease including stroke, poor blood glucose control including Type 2 Diabetes, and/ or inflammation. Test results allow doctors to know when guidance, educational referral, and/ or treatment are necessary. Key components of the CardioMetabolic Test are listed below.

CardioMetabolic Panel
  • Lipoprotein Fractionation
  • Lipoprotein Particle Numbers
  • Total Cholesterol
  • HDL Cholesterol
  • LDL Cholesterol
  • Triglycerides
  • hs-CRP
  • Homocysteine
  • Lipoprotein (a)
  • Leptin
  • Apolipoprotein A-1
  • Apolipoprotein B
  • Insulin
  • Glucose
  • Hemoglobin A1c
  • C-peptide
  • Adiponectin
  • OmegaCheckTM
  • CardioMetabolic Risk Assessment
  • Type 2 Diabetes Assessment
  • Estimated Average Glucose (eAG)
  • Homeostatic Model Assessment of
  • Insulin Resistance (HOMA-IR)

 

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

%d bloggers like this: